emerging therapies

R&D

science laboratory research and development

The role of quality assurance in accelerating drug developme...

The pharmaceutical landscape is experiencing a paradigm shift with the rise of gene therapies, cell therapies, and personalised medicine.

R&D

IPF: Could we reverse the progression?

Idiopathic Pulmonary Fibrosis (IPF) is a frightening, incurable disease where the lungs become increasingly damaged by scar tissue, resulting in breathing getting progressively more difficu

R&D

How clinical research is zeroing in on fatty liver disease

Americans’ livers are becoming increasingly unhealthy.

The role of quality assurance in accelerating drug developme...

IPF: Could we reverse the progression?

How clinical research is zeroing in on fatty liver disease

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks